Medical News

RSS

Catheter ablation treatment reduces risks associated with atrial fibrillation

New findings by researchers from the Heart Institute at Intermountain Medical Center in Murray, Utah, reveals treatment of the most common heart rhythm disorder that affects more than two million Americans significantly reduces the risk of stroke, mortality, Alzheimer's disease and other forms of dementia.

14 May 2010

Study shows correlation between good mental health and academic performance in children

Children's social-emotional competencies are directly related to how well they do in math and reading according to the results of a study presented at the annual meeting of the American Educational Research Association in Denver, Colorado.

14 May 2010

Research efforts needed to identify optimal treatments for sexual dysfunction in people with CKD

Despite the very high rate of problems with sexual function among people with chronic kidney disease (CKD), little is known about the best treatment approaches in this group of patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

14 May 2010

Sequent Medical closes $15.6M Series B venture capital financing

Sequent Medical, Inc. announced today that it has closed a $15.6 million Series B venture capital financing. The financing was led by Domain Associates, joined by existing investors Versant Ventures and US Venture Partners.

14 May 2010

TIME examines how charity T-shirt project highlights foreign aid debate

TIME reports on the recent efforts of a "young Florida businessman" who started a project "to collect a million shirts and send them to poor people in Africa." The project elicited a range of responses from people in the aid world who have been debating "the best and worst ways to deliver charity, or whether to give at all." The magazine examines these different perspectives.

14 May 2010

Medical professionals meet to standardize CT scanning techniques

A national summit of medical professionals meeting last month in Atlanta called for the creation of consensus scan techniques as a way of addressing the concerns of patients undergoing CT scans -- a common medical imaging procedure that uses X-rays to show cross-sectional images of the body.

14 May 2010

Each melanoma cell capable of cancer stem cell behavior: Study

Scientists at The Wistar Institute offer a new explanation for the persistent ability of melanoma cells to self-renew, one of the reasons why melanoma remains the deadliest form of skin cancer. The concept of the "dynamic stemness" of melanoma can explain why melanoma cells behave like both conventional tumor cells and cancer stem cells.

14 May 2010

Prometheus announces novel method for early detection of HACA during infliximab treatment

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced a new method for detecting antibody levels in individual patients treated with infliximab, a biologic therapy that has been used to treat more than a million patients across a number of autoimmune diseases, including rheumatoid arthritis, Crohn's disease and ulcerative colitis.

14 May 2010

U.N. Secretary-General discusses G8, G20 commitments during visit to Ottawa

On Wednesday, ahead of a meeting with Canadian Prime Minister Stephen Harper, U.N. Secretary-General Ban Ki-moon addressed several topics in a "speech warning that leaders of the G8 and G20 countries should not use global economic and financial difficulties as 'an excuse' to neglect previous pledges of billions of dollars for the world's poor - for doubling aid to Africa, food security, malaria and AIDS programs and maternal and child health care," Canwest News Service/Calgary Herald writes (O'Neill, 5/12).

14 May 2010

Inhibitex reports net loss of $4.8M for first-quarter 2010

Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.

14 May 2010

ISCA recommends chromosomal microarray as new standard for genetic evaluation of children

An international consortium of genetics experts has issued a consensus statement recommending chromosomal microarray (CMA) as the new standard practice for genetic evaluation of children with unexplained developmental delay, autism or birth defects.

14 May 2010

FREEDOM trial results to be presented at Heart Rhythm 2010

St. Jude Medical, Inc., a global medical device company, today announced results of the FREEDOM trial during the late breaking clinical trial presentations at Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions. The trial demonstrated that the QuickOpt optimization feature available in St. Jude Medical cardiac resynchronization therapy devices produces an equivalent response rate in CRT patients as optimization using echocardiography.

14 May 2010

NiTi Surgical Solutions completes over 4,000 successful ColonRing applications in 16 countries

NiTi™ Surgical Solutions, an innovative surgical device company, today provided an update of sales and clinical data highlights related to its lead product ColonRing™, the first major advance in reconnection technology for gastrointestinal surgery in more than 30 years.

14 May 2010

Emergent BioSolutions named Biotechnology Firm of the Year at TCM's Annual Tech Awards

Emergent BioSolutions Inc. announced today that it has been named Biotechnology Firm of the Year at the Tech Council of Maryland's Annual Tech Awards. This award acknowledges the company that best exemplifies the spirit of Maryland's biotechnology community as well as its presence and leadership within the state.

14 May 2010

St. Jude Medical announces FDA clearance and CE Mark approval for EnSite Derexi module

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) clearance, CE Mark approval and the launch of the EnSite Derexi™ module, which provides improved electrophysiology (EP) lab efficiency and workflow by enabling communication between the EnSite™ Velocity™ Cardiac Mapping System and the EP-Workmate™ Recording System.

14 May 2010

New cases of Type 1 diabetes in young children to double by 2020: The Lancet

By 2020, new cases of Type 1 diabetes in children younger than five are expected to double if current trends continue, according to a study published in The Lancet. Diabetes is an epidemic, with numbers of those suffering from diabetes and its complications increasing worldwide.

14 May 2010

India, Brazil launch trade dispute against EU, Netherlands over seizures of generic drugs

"India and Brazil launched a trade dispute against the European Union and the Netherlands on Wednesday, saying their seizures of generic drugs were hurting healthcare in poor countries and disrupting international trade," Reuters reports.

14 May 2010

Opexa Therapeutics reports lower net loss of $1.4M for first-quarter 2010

Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended March 31, 2010 and provided an update on its corporate developments.

14 May 2010

Novel vaccines for deadly diseases to be presented at AAPS' NBC

Novel vaccines for diseases ranging from the flu to HIV highlight a week's worth of biotechnology research at the American Association of Pharmaceutical Scientists' National Biotechnology Conference. Scientists from academia, industry, and government will gather at the Hilton San Francisco Union Square Sunday, May 16 -Thursday, May 20 to share research and advances in biotherapeutics.

14 May 2010

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.

14 May 2010

Medical News

Catheter ablation treatment reduces risks associated with atrial fibrillation

Study shows correlation between good mental health and academic performance in children

Research efforts needed to identify optimal treatments for sexual dysfunction in people with CKD

Sequent Medical closes $15.6M Series B venture capital financing

TIME examines how charity T-shirt project highlights foreign aid debate

Medical professionals meet to standardize CT scanning techniques

Each melanoma cell capable of cancer stem cell behavior: Study

Prometheus announces novel method for early detection of HACA during infliximab treatment

U.N. Secretary-General discusses G8, G20 commitments during visit to Ottawa

Inhibitex reports net loss of $4.8M for first-quarter 2010

ISCA recommends chromosomal microarray as new standard for genetic evaluation of children

FREEDOM trial results to be presented at Heart Rhythm 2010

NiTi Surgical Solutions completes over 4,000 successful ColonRing applications in 16 countries

Emergent BioSolutions named Biotechnology Firm of the Year at TCM's Annual Tech Awards

St. Jude Medical announces FDA clearance and CE Mark approval for EnSite Derexi module

New cases of Type 1 diabetes in young children to double by 2020: The Lancet

India, Brazil launch trade dispute against EU, Netherlands over seizures of generic drugs

Opexa Therapeutics reports lower net loss of $1.4M for first-quarter 2010

Novel vaccines for deadly diseases to be presented at AAPS' NBC

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News